ASIX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q3

FY2025Q4

FY2026Q1

365.00M

-8.33%

0.400

-54.55%

373.20M

+13.41%

0.010

-88.89%

383.30M

+1.46%

0.790

-15.05%

Estimates Revision

The market is revising No Change the revenue expectations for AdvanSix Inc. (ASIX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -10.50%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-10.50%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast ASIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASIX is 28.00 USD with a low forecast of 28.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

28.00

Averages

28.00

High

28.00

Current: 0.000

Low

28.00

Averages

28.00

High

28.00

Piper Sandler

Neutral

Overweight

upgrade

$26 -> $32

2025-05-19

Reason

Piper Sandler

Price Target

$26 -> $32

2025-05-19

upgrade

Neutral

Overweight

Reason

Piper Sandler last night upgraded AdvanSix to Overweight from Neutral with a price target of $32, up from $26. The firm cites the earnings benefit of the ammonium sulfate business as well as the relatively small impact of tariffs and the nylon, nylon intermediate and chemical intermediate businesses for the upgrade. Piper sees AdvanSix's earnings holding up better than most other chemical shares. AdvanSix's EBITDA is "far from a peak level," making the shares "significantly undervalued," Piper contends.

Piper Sandler

Neutral -> Overweight

upgrade

$26 -> $32

2025-05-18

Reason

Piper Sandler

Price Target

$26 -> $32

2025-05-18

upgrade

Neutral -> Overweight

Reason

Piper Sandler upgraded AdvanSix to Overweight from Neutral with a price target of $32, up from $26.

Piper Sandler

Charles Neivert

Buy

Hold

Downgrades

$35 → $26

2025-04-07

Reason

Piper Sandler

Charles Neivert

Price Target

$35 → $26

2025-04-07

Downgrades

Buy

Hold

Reason

Piper Sandler downgraded AdvanSix to Neutral from Overweight with a price target of $26, down from $35. The tariffs instituted by the U.S. and the likely retaliation and peripheral economic fallout from those tariffs have the potential to create "long-lasting complications" for the U.S. chemical industry, the analyst tells investors in a research note. The firm sees significant and, in some cases, irreversible negative impacts on earnings going forward. The impact will likely take the form of a loss of demand both domestically and internationally on weaker economies, reduced fixed cost absorption driving unit costs higher and margins lower, higher finance costs going forward, "and a host of other problematic outcomes," says Piper.

Piper Sandler

Charles Neivert

Buy

Maintains

$39 → $35

2025-03-18

Reason

Piper Sandler

Charles Neivert

Price Target

$39 → $35

2025-03-18

Maintains

Buy

Reason

Piper Sandler lowered the firm's price target on AdvanSix to $35 from $39 and keeps an Overweight rating on the shares. The firm cites the release of Q4 2024 and FY2024 earnings results, new 2025 guidance from the company and its own channel checks and estimates for 2025 and 2026. Overall, Piper sees a substantial year-over-year gain in EBITDA for 2025 as AS and acetone continue to contribute strongly to earnings going forward. Nylon, caprolactam and amines, along with other products in the Chemical Intermediates segment, should contribute more modest upside as U.S. and global economic growth remains muted, the firm adds.

Valuation Metrics

The current forward P/E ratio for AdvanSix Inc (ASIX.N) is 6.11, compared to its 5-year average forward P/E of 10.24. For a more detailed relative valuation and DCF analysis to assess AdvanSix Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

10.24

Current PE

6.11

Overvalued PE

18.00

Undervalued PE

2.49

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

5.60

Current EV/EBITDA

5.07

Overvalued EV/EBITDA

7.02

Undervalued EV/EBITDA

4.18

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.53

Current PS

0.29

Overvalued PS

0.66

Undervalued PS

0.40

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

ASIX News & Events

Events Timeline

No data

News

5.0

2025-12-22Businesswire

AdvanSix Appoints Jeffrey Bird to Board of Directors Effective January 2026

2.0

2025-12-05PRnewswire

S&P 500 Index Adjustments: Six New Additions Announced

2.0

2025-12-05Newsfilter

S&P 500 Index Adjustments: Additions of CRH and Others

People Also Watch

Frequently Asked Questions

What is AdvanSix Inc (ASIX) stock price today?

The current price of ASIX is 18.49 USD — it has increased 1.71 % in the last trading day.

What is AdvanSix Inc (ASIX)'s business?

AdvanSix Inc. is a diversified chemistry company that produces essential materials for its customers in a variety of end markets and applications, including building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics. Its product lines include nylon solutions, plant nutrients, and chemical intermediates. It sells its Nylon 6 resin globally, under the Aegis brand name. It markets and sells ammonium sulfate to North American and South American distributors, farm cooperatives and retailers to fertilize crops. It also manufactures sulfuric acid, ammonia and carbon dioxide. It manufactures, markets and sells a number of chemical intermediate products. Its other intermediate chemicals include phenol, alpha-methyl styrene (AMS), cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines. Additional end-products for intermediates include automotive components, and water treatment and pharmaceutical intermediates.

What is the price predicton of ASIX Stock?

What is AdvanSix Inc (ASIX)'s revenue for the last quarter?

AdvanSix Inc revenue for the last quarter amounts to 374.47M USD, decreased -5.96 % YoY.

What is AdvanSix Inc (ASIX)'s earnings per share (EPS) for the last quarter?

AdvanSix Inc. EPS for the last quarter amounts to -0.10 USD, decreased -112.20 % YoY.

What changes have occurred in the market's expectations for AdvanSix Inc (ASIX)'s fundamentals?

How many employees does AdvanSix Inc (ASIX). have?

AdvanSix Inc (ASIX) has 1450 emplpoyees as of January 10 2026.

What is AdvanSix Inc (ASIX) market cap?

Today ASIX has the market capitalization of 496.72M USD.